Bayer launches new platform to address challenges in radiology
This week Bayer announced the launch of Calantic Digital Solutions, a suite of applications intended to optimize clinical workflows by triaging and prioritizing critical findings, improving disease detection and automating tasks for radiologists.
In a statement released June 28, Bayer indicated that the cloud-hosted platform, which includes AI-enabled programs, can aid radiologists in navigating the mounting workloads they are faced with in the wake of nationwide staff shortages.
“AI has the potential to transform healthcare, and, particularly in medical imaging, it can turn the growing amounts of data into value-adding insights to support radiologists and their teams in their decision-making,” Dr. Ryan Lee, Chair, Department of Radiology, Einstein Healthcare Network, Philadelphia, said in the release. “It is crucial to drive innovation in this area and broaden access to digital tools that can help address the rising demand for solutions which improve the speed and accuracy of diagnoses.”
To better manage radiology workflows, the apps focus on three key areas: triaging and prioritizing potentially urgent findings that merit timely review, improving lesion detection, and automating routine tasks and measurements.
“Built on our leading industry knowledge and deep medical understanding across a multitude of diagnostic and therapeutic areas, Calantic Digital Solutions underlines our commitment to continue accelerating innovation for the benefit of patients and their physicians,” said Gerd Krüger, Head of Radiology, Bayer Pharmaceuticals. “With Calantic Digital Solutions, we are entering the fastest growing segment in the radiology market and taking the next step from a product provider to a solution provider, following our mission to provide an ecosystem of third-party and Bayer products to deliver innovative disease-oriented solutions for radiologists and their teams.”
Currently, the applications are centered on thoracic and neurological diseases (pulmonary nodules, large vessel occlusions, etc.), with the addition of more disease-specific packages on the horizon. Bayer indicates that they provide the installation, configuration and training for the Calantic platform.
For more information, click here.
In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.